title: Chemoradiotherapy in the treatment of inoperable high-grade osteosarcoma.
abstract: Radical surgery is not feasible for all osteosarcoma patients. Overall survival for non-extremity osteosarcoma, as well as for patients with metastatic disease at diagnosis remains poor. For such patients, radical radiotherapy combined with chemotherapy may present an effective treatment approach. This report describes the results of conservative treatment for osteosarcoma patients not suitable for surgery. Seven out of 71 consecutive osteosarcoma patients were treated non-surgically at the Helsinki University Central Hospital either due to the inoperability of the tumour or the patient's choice of therapy. Staging procedures and measurement of tumour size were performed using computed tomography and magnetic resonance imaging. Six patients were treated with chemo-radiotherapy, and one patient received radiotherapy alone. Five patients received computer-assisted dose-planned radiotherapy with curative intent (total dose 60-70.5 Gray), and two patients received radiotherapy as palliation. Radiotherapy relieved symptoms efficiently. Median time to local failure was 2.6 years (range 0.5-16.9+ years). Five year after treatment termination four patients were alive, and one of them remained disease-free. For selected patients not suitable for surgery, radiotherapy combined with chemotherapy provides an option to reduce symptoms caused by the primary tumour and improve quality of life. For some patients, this approach may (even) produce long-term remission.
authors.affiliation: Department of Oncology, Helsinki University Central Hospital, and Department of Pathology, HUSLAB, University of Helsinki, P.O. Box 180, 00029 HUS, Helsinki, Finland. micaela.hernberg@pp.inet.fi
authors.forename: Micaela M
authors.initials: MM
authors.lastname: Hernberg
authors.forename: Aarne H
authors.initials: AH
authors.lastname: Kivioja
authors.forename: Tom O
authors.initials: TO
authors.lastname: Böhling
authors.forename: Rita J
authors.initials: RJ
authors.lastname: Janes
authors.forename: Tom A
authors.initials: TA
authors.lastname: Wiklund
mesh_terms: D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000401:mortality / Q000628:therapy*; D059248:Chemoradiotherapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012516:Osteosarcoma / Q000401:mortality / Q000628:therapy*; D011880:Radiotherapy Planning, Computer-Assisted; D012189:Retrospective Studies; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents